Navigation Links
As Breast Augmentation Becomes the No. 1 Cosmetic Surgery Procedure, New Jersey Plastic Surgeon Paul LoVerme, MD Discusses the Safety of Silicone Breast Implants
Date:3/25/2009

18 years ago, silicone breast implants were pulled from the market for further study. Now, after being formally approved for use by the U.S. Food and Drug Administration in 2006, one New Jersey cosmetic plastic surgeon discusses the reasons why the FDA’s decision is beneficial to breast augmentation and breast reconstruction patients.

(Vocus) March 25, 2009 -- New statistics from the American Society for Aesthetic Plastic Surgery report that, for the first time in twelve years, breast augmentation has surpassed liposuction to become the most popular cosmetic surgical procedure in the United States. More than 355,000 breast augmentation surgeries were performed last year. The new report coincides with the two-year anniversary of a landmark decision from the U.S. Food and Drug Administration allowing doctors to use silicone breast implants in breast surgery procedures.

In 1991, following a series of high-profile lawsuits, the FDA decided to pull silicone breast implants off the market. In 2006, after years of intensive study and clinical trials, the organization decided to approve the use of the implants in breast augmentation patients over the age of 22, and breast reconstruction patients of any age. Dr. Paul LoVerme is a New Jersey cosmetic plastic surgeon and head of the LoVerme Center for Plastic Surgery in Verona. He says the FDA’s decision is ultimately good for patients. “Silicone implants were taken off the market with some allegations that over the last 14 years have not proved to be true. There really is no greater risk to women with silicone implants than there is with saline implants, but there are some differences.”

Those differences are mainly apparent in the appearance and feel of the implant, and what happens if the implant ruptures. With saline implants, a rupture or leak in the implant is easily detectable as the breast takes on a deflated appearance. Since silicone breast implants use a viscous, silicone gel as their main component, a leak may be harder to detect. “With a silicone implant we may have a silent rupture and it may not be detectable except by MRI or perhaps physical examination by the plastic surgeon.” However, many doctors say silicone breast implants are extremely durable, and that years of rigorous testing and study show that silicone implants are not harmful. Dr. LoVerme says one of the most positive aspects of the FDA’s decision is that it gives patients like those at his New Jersey breast augmentation practice a broader range of options to meet their own specific needs. “You know it’s great that silicone implants are now back on the market because it gives women a choice.”

Silicone breast implants are often said to look and feel more natural than their saline counterparts, and are less prone to rippling. Dr. LoVerme says the choice between silicone and saline implants is ultimately up to the patient, and he provides detailed advice on both implants so that individuals can make educated choices about what they feel is right for them. “Some women still are uncomfortable with silicone implants and that’s fine and I still use saline implants for those women. Other women have actually waited until silicone gel implants were available because they do have a more natural feel, especially in women with very small breasts to begin with. I have women who have exchanged saline implants for silicone implants and they can’t believe how much more comfortable and natural they feel.”

Dr. LoVerme says the most important thing for patients to do before undergoing breast enlargement is to educate themselves about the procedure, and be sure to have an understanding about both types of implants. “I have a lot of things on my website and I spend a lot of time speaking with patients when they come into the office about breast augmentation, about the differences between saline and silicone. And I’m not one that tries to push you to one implant or the other. I really look at myself as a resource… I’m here to help you make that final decision.”

Dr. Paul LoVerme is a board-certified plastic surgeon who has been recognized as “Top Doctor” in the New York and New Jersey area by the Castle-Connolly Guide, N.J. Monthly, and N.Y. Magazine. A past president of the New Jersey Society of Plastic Surgeons, Dr. LoVerme is an associate professor of Plastic Surgery at UMDNJ - New Jersey Medical School. His New Jersey breast implants facility is accredited by the American Association for Accreditation of Ambulatory Surgery Facilities, Inc. (AAAASF), with a fully operational surgical suite on-site.

New Jersey silicone breast implant surgeon, Dr. Paul LoVerme can be reached at the LoVerme Center for Plastic Surgery at 825 Bloomfield Ave., Suite 205, Verona, New Jersey 07044 – (973) 857-9499, or via his website at www.LoVermeCenter.com.

###

Read the full story at http://www.prweb.com/releases/2009/03/prweb2262394.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Risk of aggressive breast cancer subtype 3 times higher for black women
2. Eating soy early in life may reduce breast cancer among Asian women
3. New test may predict spread of breast cancer
4. Quality of life may impact coping strategies of young women with breast cancer
5. Young Survival Coalition and Living Beyond Breast Cancer Announce Support for Rep. Wasserman Schultzs The Early Act
6. Susan G. Komen for the Cure(R) Advocacy Alliance Supports Effort to Encourage Early Breast Health Education
7. Super micro-surgery offers new hope for breast cancer patients with lymphedema
8. Hospital Practices Influence Which Moms Will Breast-Feed
9. Research shows biopsy of recurrent breast cancer can alter treatment
10. Penn researchers identify new protein important in breast cancer genes role in DNA repair
11. When Breast Cancer Recurs, Finding Pre-Symptoms Is Key
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
As Breast Augmentation Becomes the No. 1 Cosmetic Surgery Procedure, New Jersey Plastic Surgeon Paul LoVerme, MD Discusses the Safety of Silicone Breast Implants
(Date:3/30/2017)... , ... March 30, 2017 , ... ... the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ” with ... at 1:00 pm ET. This conference discusses strategies to prevent readmissions in light ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... squash, announced it has enlisted New York City-based sports and entertainment marketing firm ... and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, ... Spice", it has been used for thousands of years. , "The West has caught ... of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based ... into the challenges employers face in trying to balance both short-term and long-term ... programs? Adding to the growing complexity, companies are finding that the short-term ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... Device Library for documenting and diagramming network and data center assets and audio-video ... NetZoom subscribers can request new equipment shapes for free and download shapes and ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... at Proton Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in ... its market value in 2016. There are currently three proton therapy centers ... to treat more patients. In Italy , the first ...
(Date:3/29/2017)... 2017  Providence Medical Technology, Inc., an innovator ... two industry veterans to the commercial leadership team.  ... to lead Global Marketing, and Michael Scott ... and Mr. Scott have over 40 years of ... joins the company with over 22 years of ...
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
Breaking Medicine Technology: